HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyden's Rx Pseudoephedrine Bill On Doorstep As States Continue Meth Fight

This article was originally published in The Tan Sheet

Executive Summary

Sen. Ron Wyden says he will introduce legislation to make pseudoephedrine-containing drugs available by prescription only - a measure that could gain traction among states waging their own battles against methamphetamine

You may also be interested in...



Senate Meth Fight Pits Rx-Only Pseudoephedrine Against E-Tracking Option

The debate over how best to keep methamphetamine precursors from diversion to illicit drug labs is coming to a head as lawmakers stake out positions and legislation to restrict nonprescription access to pseudoephedrine waits in the wings

Mississippi PSE Prescription Switch Will Not Start An Avalanche - CHPA

Mississippi lawmakers' decision to make all pseudoephedrine-containing drugs prescription-only will not prompt other states combating methamphetamine to do the same, the Consumer Healthcare Products Association predicts

Wyden To Propose Prescription-Only Status For Pseudoephedrine

Legislation drafted by Sen. Ron Wyden would require prescriptions for all products containing the methamphetamine precursor pseudoephedrine

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS135533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel